Europe’s Committee for Medicinal Products for Human Use has recommended that Bluebird Bio’s lentiglobin, or Zynteglo, gene therapy for beta-thalassemia be approved. The treatment inserts a copy of the beta-globin gene into bone marrow cells.
Like millions of other Americans, Victoria Gray has been sheltering at home with her children as the U.S. struggles through a deadly pandemic, and as protests over police violence have erupted across the country. But Gray is not like any other American. She’s the first